XMD16-5

CAS: 1345098-78-3

Ref. 3D-VDC09878

Produktinformation

• Name: XMD16-5
• CAS: 1345098-78-3

Beschreibung

XMD16-5 is a pharmacologic drug that inhibits the activity of a number of tyrosine kinases, including platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR). XMD16-5 has been shown to be effective in leukemia cells. It has also been shown to inhibit the activity of BCR-ABL, an oncogenic tyrosine kinase. XMD16-5 is a multi-kinase inhibitor with targetable properties. It has been shown to have a high degree of selectivity for PDGFR and VEGFR over other kinases. This drug is being developed by Novartis as a targeted therapy for cancers with activating mutations in these two receptors.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 416.48 g/mol
• Formel: C₂₃H₂₄N₆O₂
• Reinheit: Min. 95%